Delivery Order SPE2DB22D6029-SPE2DB25FLTRV

Award Date 1/10/25
Potential Completion Date 2/3/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,645.34 delivery order contract is for the supply of IMBRUVICA 420 MG TABLET 28S, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,151.52 firm fixed-price delivery order is for the supply of IMBRUVICA 420 MG TABLET 28S, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 420 mg tablets, a specialty medication, with a ceiling value of $7,575.75 and a completion date of January 24, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. In addition to this specific delivery order, AmerisourceBergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,645.34, is for the delivery of IMBRUVICA 280 MG tablets. It is a firm-fixed-price delivery order contract with a completion date of November 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 140 MG TABLET 28S, a pharmaceutical product, with a ceiling value of $15,151.50 and an ultimate completion date of April 30, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,575.75 firm-fixed-price delivery order is for the supply of IMBRUVICA 420 MG TABLET 28S, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of IMBRUVICA 140 MG TABLET 28S. The $7,575.75 fixed-price contract has a completion date of March 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026, which serves as a primary vehicle for providing...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 420 MG TABLET 28S, a pharmaceutical product, with a ceiling value of $15,151.52 and a period of performance through June 25, 2025. The contract is designated as a firm fixed-price delivery order, without any set-aside requirements. Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of IMBRUVICA 420 MG TABLET 28S. The fixed-price contract has a ceiling value of $37,878.75 and a performance period through July 23, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This federal contract award, valued at $21,644.98, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 140 MG CAPSULE 120S, a specialty oncology medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division. This IDC serves as a...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB25FLTRV
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a Ceiling Value of $15,151.52 and is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The contract provides for the delivery of IMBRUVICA 280 MG TABLET 28S, a prescription medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award does not have a set-aside designation, indicating open competition. As a large, established vendor in the federal healthcare supply chain, Amerisourcebergen maintains several IDCs with the DLA and other agencies to provide a comprehensive range of pharmaceutical products and medical supplies for various federal healthcare programs.

Generated 4/11/25, 11:03 AM